Usefulness of methionine PET for response evaluation and predicting prognosis of uterine cervical cancer treated by carbon-ion beam radiotherapy

被引：0
|
作者：
Yoshikawa, K. [1 ]
Ohashi, S. [1 ]
Toubaru, S. [1 ]
Hasebe, M. [1 ]
Ishikawa, H. [1 ]
Sagou, K. [1 ]
Tamura, K. [1 ]
Tanimoto, K. [1 ]
Kiyohara, H. [1 ]
Kato, S. [1 ]
Kandatsu, S. [1 ]
Fukumura, T. [1 ]
Saga, T. [1 ]
Tsujii, H. [1 ]
机构：
[1] Natl Inst Radiol Sci, Chiba 260, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S203 / S203
页数：1
相关论文
共 50 条
  • [1] Usefulness of C-11 methionine PET/CT for predicting recurrence, metastasis and prognosis of patients with lung cancer treated by carbon ion radiotherapy
    Toubaru, S.
    Yoshikawa, K.
    Ohashi, S.
    Hasebe, M.
    Ishikawa, H.
    Sagou, K.
    Tamura, K.
    Tanimoto, K.
    Kandatsu, S.
    Baba, M.
    Fukumura, T.
    Saga, T.
    Kawaguchi, K.
    Hamada, Y.
    Tsujii, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S333 - S333
  • [2] Secondary cancers after carbon-ion radiotherapy and photon beam radiotherapy for uterine cervical cancer: A comparative study
    Nitta, Yuki
    Murata, Hiroto
    Okonogi, Noriyuki
    Murata, Kazutoshi
    Wakatsuki, Masaru
    Karasawa, Kumiko
    Kato, Shingo
    Yamada, Shigeru
    Nakano, Takashi
    Tsuji, Hiroshi
    [J]. CANCER MEDICINE, 2022, 11 (12): : 2445 - 2454
  • [3] Metabolic Tumor Volume of Methionine PET in Early Lung Cancer is Useful for Predicting Prognosis of Patients treated with Carbon Ion Radiotherapy
    Tamura, Kentaro
    Nishii, Ryuichi
    Yamazaki, Kana
    Yamamoto, Naoyoshi
    Higashi, Tatsuya
    Tsuji, Hiroshi
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [4] Cervical spine osteosarcorna treated with carbon-ion radiotherapy
    Imai, Reiko
    Kamada, Tadashi
    Tsuji, Hiroshi
    Tsujii, Hirohiko
    Tsuburai, Yoshiharu
    Tatezaki, Shin-ichiro
    [J]. LANCET ONCOLOGY, 2006, 7 (12): : 1034 - 1035
  • [5] Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Predicting Prognosis in Pancreatic Cancer Treated With Carbon-Ion Radiotherapy
    Shinoto, M.
    Suefuji, H.
    Terashima, K.
    Toyama, S.
    Shioyama, Y.
    [J]. PANCREAS, 2017, 46 (10) : 1435 - 1435
  • [6] Prophylactic extended-field carbon-ion radiotherapy for locally advanced uterine cervical cancer
    Wakatsuki, M.
    Kato, S.
    Ohno, T.
    Karasawa, K.
    Irie, D.
    Ando, K.
    Kiyohara, H.
    Nakano, T.
    Kamada, T.
    Shozu, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S42 - S42
  • [7] Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion
    Shiba, Shintaro
    Wakatsuki, Masaru
    Kato, Shingo
    Ohno, Tatsuya
    Okonogi, Noriyuki
    Karasawa, Kumiko
    Kiyohara, Hiroki
    Tsujii, Hirohiko
    Nakano, Takashi
    Kamada, Tadashi
    Shozu, Makio
    [J]. JOURNAL OF RADIATION RESEARCH, 2016, 57 (06) : 684 - 690
  • [8] Carbon-11-methionine pet imaging in patients with uterine cervical cancer
    Tamura, K.
    Yoshikawa, K.
    Ishikawa, H.
    Ishida, J.
    Abe, Y.
    Kubo, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S262 - S262
  • [9] Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508)
    Wakatsuki, Masaru
    Kato, Shingo
    Kiyohara, Hiroki
    Ohno, Tatsuya
    Karasawa, Kumiko
    Tamaki, Tomoaki
    Ando, Ken
    Tsujii, Hirohiko
    Nakano, Takashi
    Kamada, Tadashi
    Shozu, Makio
    [J]. PLOS ONE, 2015, 10 (05):
  • [10] Evaluation of Safety for Scanning Carbon-Ion Radiotherapy in Hemodialysis Patients With Prostate Cancer
    Takakusagi, Yosuke
    Suga, Makito
    Kusano, Yohsuke
    Kano, Kio
    Shima, Satoshi
    Tsuchida, Keisuke
    Mizoguchi, Nobutaka
    Serizawa, Itsuko
    Yoshida, Daisaku
    Kamada, Tadashi
    Minohara, Shinichi
    Katoh, Hiroyuki
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
12345